JP2013543499A5 - - Google Patents

Download PDF

Info

Publication number
JP2013543499A5
JP2013543499A5 JP2013531966A JP2013531966A JP2013543499A5 JP 2013543499 A5 JP2013543499 A5 JP 2013543499A5 JP 2013531966 A JP2013531966 A JP 2013531966A JP 2013531966 A JP2013531966 A JP 2013531966A JP 2013543499 A5 JP2013543499 A5 JP 2013543499A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
amino acid
polypeptide
residues
acid sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013531966A
Other languages
English (en)
Japanese (ja)
Other versions
JP6029586B2 (ja
JP2013543499A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2011/054831 external-priority patent/WO2012047941A2/en
Publication of JP2013543499A publication Critical patent/JP2013543499A/ja
Publication of JP2013543499A5 publication Critical patent/JP2013543499A5/ja
Application granted granted Critical
Publication of JP6029586B2 publication Critical patent/JP6029586B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013531966A 2010-10-04 2011-10-04 血球凝集素ポリペプチド、ならびにそれに関連する試薬および方法 Active JP6029586B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US38963910P 2010-10-04 2010-10-04
US61/389,639 2010-10-04
PCT/US2011/054831 WO2012047941A2 (en) 2010-10-04 2011-10-04 Hemagglutinin polypeptides, and reagents and methods relating thereto

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2016030091A Division JP6143902B2 (ja) 2010-10-04 2016-02-19 血球凝集素ポリペプチド、ならびにそれに関連する試薬および方法

Publications (3)

Publication Number Publication Date
JP2013543499A JP2013543499A (ja) 2013-12-05
JP2013543499A5 true JP2013543499A5 (enExample) 2014-11-20
JP6029586B2 JP6029586B2 (ja) 2016-11-24

Family

ID=44860519

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2013531966A Active JP6029586B2 (ja) 2010-10-04 2011-10-04 血球凝集素ポリペプチド、ならびにそれに関連する試薬および方法
JP2016030091A Active JP6143902B2 (ja) 2010-10-04 2016-02-19 血球凝集素ポリペプチド、ならびにそれに関連する試薬および方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2016030091A Active JP6143902B2 (ja) 2010-10-04 2016-02-19 血球凝集素ポリペプチド、ならびにそれに関連する試薬および方法

Country Status (10)

Country Link
US (2) US10226527B2 (enExample)
EP (1) EP2624864B1 (enExample)
JP (2) JP6029586B2 (enExample)
CN (1) CN103328002B (enExample)
AU (1) AU2011312178B2 (enExample)
BR (1) BR112013007946B1 (enExample)
CA (1) CA2813078A1 (enExample)
RU (1) RU2663718C2 (enExample)
SG (2) SG189236A1 (enExample)
WO (1) WO2012047941A2 (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2813078A1 (en) 2010-10-04 2012-04-12 Massachusetts Institute Of Technology Hemagglutinin polypeptides, and reagents and methods relating thereto
AR083533A1 (es) * 2010-10-22 2013-03-06 Boehringer Ingelheim Vetmed Proteinas de hemaglutinina 5 (h5) para el tratamiento y prevencion de las infecciones de gripe
CN103930435A (zh) 2011-09-30 2014-07-16 麦迪卡格公司 增加植物中病毒样颗粒的产率
US11390878B2 (en) 2011-09-30 2022-07-19 Medicago Inc. Increasing protein yield in plants
US9969794B2 (en) 2012-05-10 2018-05-15 Visterra, Inc. HA binding agents
SG11201406769RA (en) 2012-05-10 2014-11-27 Massachusetts Inst Technology Agents for influenza neutralization
AU2014214754B2 (en) * 2013-02-07 2018-07-12 Massachusetts Institute Of Technology Human adaptation of H5 influenza
KR20150127586A (ko) 2013-03-15 2015-11-17 더 트러스티스 오브 더 유니버시티 오브 펜실바니아 인플루엔자 핵산 분자 및 이로부터 제조된 백신
IL241692B2 (en) 2013-03-28 2023-12-01 Medicago Inc Influenza virus-like particle production in plants
US12467058B2 (en) * 2013-03-28 2025-11-11 Aramis Biotechnologies Inc. Influenza virus-like particle production in plants
ES2864081T3 (es) 2014-01-10 2021-10-13 Medicago Inc Elementos potenciadores de CPMV
EP3233117A4 (en) * 2014-12-19 2018-05-16 Oregon Health & Science University Synergistic co-administration of computationally optimized broadly reactive antigens for human and avian h5n1 influenza
EP3374390A1 (en) 2015-11-13 2018-09-19 Visterra, Inc. Compositions and methods for treating and preventing influenza
JP7104629B2 (ja) 2016-02-24 2022-07-21 ビステラ， インコーポレイテッド インフルエンザウイルスに対する抗体分子の製剤
US12258540B2 (en) 2017-10-30 2025-03-25 Takeda Pharmaceutical Company Limited Environmentally compatible detergents for inactivation of lipid-enveloped viruses
AU2020248404A1 (en) 2019-03-25 2021-09-30 Visterra, Inc. Compositions and methods for treating and preventing influenza
CN110172452B (zh) * 2019-05-21 2021-07-06 广州医科大学 一种高致病性h7n9禽流感病毒、疫苗、检测试剂以及病毒、疫苗的制备方法
JP2022038604A (ja) 2020-08-27 2022-03-10 株式会社Subaru 車両の制御装置

Family Cites Families (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4166452A (en) 1976-05-03 1979-09-04 Generales Constantine D J Jr Apparatus for testing human responses to stimuli
US4270537A (en) 1979-11-19 1981-06-02 Romaine Richard A Automatic hypodermic syringe
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4692411A (en) 1983-09-06 1987-09-08 Ghose Rabindra N Separation of specific biological cells by a biochemical filter
US4596556A (en) 1985-03-25 1986-06-24 Bioject, Inc. Hypodermic injection apparatus
US4886499A (en) 1986-12-18 1989-12-12 Hoffmann-La Roche Inc. Portable injection appliance
GB8704027D0 (en) 1987-02-20 1987-03-25 Owen Mumford Ltd Syringe needle combination
US4941880A (en) 1987-06-19 1990-07-17 Bioject, Inc. Pre-filled ampule and non-invasive hypodermic injection device assembly
US4790824A (en) 1987-06-19 1988-12-13 Bioject, Inc. Non-invasive hypodermic injection device
US4940460A (en) 1987-06-19 1990-07-10 Bioject, Inc. Patient-fillable and non-invasive hypodermic injection device assembly
US5698390A (en) 1987-11-18 1997-12-16 Chiron Corporation Hepatitis C immunoassays
US5339163A (en) 1988-03-16 1994-08-16 Canon Kabushiki Kaisha Automatic exposure control device using plural image plane detection areas
FR2638359A1 (fr) 1988-11-03 1990-05-04 Tino Dalto Guide de seringue avec reglage de la profondeur de penetration de l'aiguille dans la peau
US5064413A (en) 1989-11-09 1991-11-12 Bioject, Inc. Needleless hypodermic injection device
US5312335A (en) 1989-11-09 1994-05-17 Bioject Inc. Needleless hypodermic injection device
EP0438803B1 (en) 1990-01-26 1997-03-12 Immunomedics, Inc. Vaccines against cancer and infectious diseases
US5190521A (en) 1990-08-22 1993-03-02 Tecnol Medical Products, Inc. Apparatus and method for raising a skin wheal and anesthetizing skin
US5527288A (en) 1990-12-13 1996-06-18 Elan Medical Technologies Limited Intradermal drug delivery device and method for intradermal delivery of drugs
GB9118204D0 (en) 1991-08-23 1991-10-09 Weston Terence E Needle-less injector
SE9102652D0 (sv) 1991-09-13 1991-09-13 Kabi Pharmacia Ab Injection needle arrangement
US5328483A (en) 1992-02-27 1994-07-12 Jacoby Richard M Intradermal injection device with medication and needle guard
US5383851A (en) 1992-07-24 1995-01-24 Bioject Inc. Needleless hypodermic injection device
US5569189A (en) 1992-09-28 1996-10-29 Equidyne Systems, Inc. hypodermic jet injector
US5334144A (en) 1992-10-30 1994-08-02 Becton, Dickinson And Company Single use disposable needleless injector
US5500161A (en) 1993-09-21 1996-03-19 Massachusetts Institute Of Technology And Virus Research Institute Method for making hydrophobic polymeric microparticles
WO1995024176A1 (en) 1994-03-07 1995-09-14 Bioject, Inc. Ampule filling device
US5466220A (en) 1994-03-08 1995-11-14 Bioject, Inc. Drug vial mixing and transfer device
US5599302A (en) 1995-01-09 1997-02-04 Medi-Ject Corporation Medical injection system and method, gas spring thereof and launching device using gas spring
US5730723A (en) 1995-10-10 1998-03-24 Visionary Medical Products Corporation, Inc. Gas pressured needle-less injection device and method
US5893397A (en) 1996-01-12 1999-04-13 Bioject Inc. Medication vial/syringe liquid-transfer apparatus
GB9607549D0 (en) 1996-04-11 1996-06-12 Weston Medical Ltd Spring-powered dispensing device
US5993412A (en) 1997-05-19 1999-11-30 Bioject, Inc. Injection apparatus
IT1298087B1 (it) 1998-01-08 1999-12-20 Fiderm S R L Dispositivo per il controllo della profondita' di penetrazione di un ago, in particolare applicabile ad una siringa per iniezioni
CN1196788C (zh) 2000-06-23 2005-04-13 惠氏控股有限公司 野生型和嵌合流感病毒样颗粒(vlp)的装配
US8592197B2 (en) 2003-07-11 2013-11-26 Novavax, Inc. Functional influenza virus-like particles (VLPs)
US7504109B2 (en) * 2004-05-25 2009-03-17 Medimmune, Llc Influenza hemagglutinin and neuraminidase variants
WO2006108226A1 (en) 2005-04-12 2006-10-19 The University Of Queensland Vaccine delivery system
WO2007051036A2 (en) 2005-10-26 2007-05-03 Protelix, Inc. Influenza combinatorial antigen vaccine
SG169375A1 (en) * 2006-02-02 2011-03-30 Globeimmune Inc Yeast-based vaccine for inducing an immune response
US8778353B2 (en) 2006-05-01 2014-07-15 Technovax, Inc. Influenza virus-like particle (VLP) compositions
US9101578B2 (en) 2006-05-01 2015-08-11 Technovax, Inc. Polyvalent influenza virus-like particle (VLP) compositions
WO2008054535A2 (en) 2006-05-11 2008-05-08 Novavax, Inc. Novel influenza m2 vaccines
US20100143406A1 (en) 2006-06-30 2010-06-10 Gale Smith Methods of enhancing protein incorporation into virus like particles
JP5683811B2 (ja) 2006-07-27 2015-03-11 タケダ ヴァクシーンズ， インコーポレイテッド キメラインフルエンザウイルス様粒子
CA2657955A1 (en) 2006-07-27 2008-08-07 Ligocyte Pharmaceuticals, Inc. Chimeric virus-like particles
JP2010500034A (ja) * 2006-08-09 2010-01-07 メッドイミューン バクシーンズ，インコーポレイティド インフルエンザ赤血球凝集素変異体およびノイラミニダーゼ変異体
US20080241918A1 (en) 2006-08-14 2008-10-02 Ram Sasisekharan Hemagglutinin polypeptides, and reagents and methods relating thereto
US20090269342A1 (en) 2006-08-14 2009-10-29 Massachusetts Institute Of Technology Hemagglutinin Polypeptides, and Reagents and Methods Relating Thereto
CN101553502A (zh) 2006-08-14 2009-10-07 麻省理工学院 血球凝集素多肽和其相关试剂和方法
AU2007304883B2 (en) 2006-10-04 2013-09-05 The University Of Queensland VLP based vaccine delivery system
KR20090101883A (ko) * 2006-10-10 2009-09-29 더 거번먼트 오브 더 유나이티드 스테이츠 오브 어메리카 애즈 레프리젠티드 바이 더 세크러터리 오브 더 디파트먼트 오브 헬쓰 앤드 휴먼 써비시즈 조류 인플루엔자 백신
US8202967B2 (en) 2006-10-27 2012-06-19 Boehringer Ingelheim Vetmedica, Inc. H5 proteins, nucleic acid molecules and vectors encoding for those, and their medicinal use
WO2008061243A2 (en) 2006-11-16 2008-05-22 Novavax, Inc. Respiratory syncytial virus-virus like particle (vlps)
MX2009007106A (es) 2006-12-29 2010-04-30 Inst Pasteur Of Shanghai Lentivirus pseudotipificado con hemaglutinina de influenza y metodos de uso.
WO2008148104A1 (en) 2007-05-25 2008-12-04 Novavax, Inc. Novel vlps derived from cells that do not express a viral matrix or core protein
CA2615372A1 (en) 2007-07-13 2009-01-13 Marc-Andre D'aoust Influenza virus-like particles (vlps) comprising hemagglutinin
EP2176427A4 (en) 2007-07-19 2011-10-05 Novavax Inc VIRAL PESUDO-PARTICLES OF THE CHIMÈRE AVIAN INFLUENZA
EP2238146A4 (en) * 2008-01-03 2012-03-21 Massachusetts Inst Technology HEMAGGLUTININE POLYPEPTIDES AND REAGENTS AND METHODS RELATED THEREWITH
EP2237787A4 (en) 2008-01-03 2012-03-21 Massachusetts Inst Technology DECOY-INFLUENZA THERAPIES
DK2318530T3 (en) 2008-07-18 2016-10-03 Medicago Inc Ny epitope to immunization against influenza
JP5886194B2 (ja) 2009-07-02 2016-03-16 マサチューセッツ インスティテュート オブ テクノロジー インフルエンザ感染の診断および／または処置のための組成物および方法
CA2813078A1 (en) 2010-10-04 2012-04-12 Massachusetts Institute Of Technology Hemagglutinin polypeptides, and reagents and methods relating thereto
AU2014214754B2 (en) 2013-02-07 2018-07-12 Massachusetts Institute Of Technology Human adaptation of H5 influenza

Similar Documents

Publication Publication Date Title
JP2013543499A5 (enExample)
RU2013114424A (ru) Полипептиды гемагглютининов, а также связанные с ними реагенты и способы
JP2016222689A5 (ja) 合成ペプチド及び乾燥粉末薬剤輸送システム
JP2016509011A5 (enExample)
JP2012115277A5 (enExample)
JP2016534034A5 (enExample)
JP2017048194A5 (enExample)
JP2017507181A5 (enExample)
JP2016512425A5 (enExample)
JP2012126742A5 (enExample)
JP2016199557A5 (enExample)
JP2015526391A5 (enExample)
JP2010065037A5 (enExample)
EA201190108A1 (ru) Фармацевтическая композиция для ингаляции
JP2015506705A5 (enExample)
JP2013510169A5 (enExample)
JP2013541528A5 (enExample)
EA201590030A1 (ru) Ингаляторы сухого порошка, содержащие носитель, отличный от лактозы, и третий компонент
JP2014529399A5 (enExample)
RU2017119773A (ru) Пептидные антагонисты пептидных гормонов из семейства кальцитонина (cgrp) и их применение
RU2017124487A (ru) НОВЫЙ ПЕПТИД-ИНГИБИТОР PI3Kγ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ ОРГАНОВ ДЫХАНИЯ
JP2017532965A5 (enExample)
CL2007003754A1 (es) Compuestos derivados de aril(heteroaril)alquil-amina; proceso de preparacion; compuestos intermediarios; composicion farmaceutica; combinacion farmaceutica; y uso en el tratamiento de enfermedades tales como bronquitis, enfisema pulmonar y epoc.
WO2011094430A3 (en) Pro-angiogenic fragments of prominin-1 and uses thereof
JP2010265269A5 (enExample)